We identified focal adhesion kinase (FAK) as one such potential target and demonstrated that inhibition of FAK in primary CLL samples effectively reduces both CXCL12 induced migration and invasion in vitro. The gene discussed is CXCL12; the disease is B-cell chronic lymphocytic leukemia.